Clinical diagnostics involve detection and diagnosis of various medical conditions based on the samples collected from human body such as blood, urine, tissue etc. These diagnostic tests help medical professionals to detect diseases, monitor drug therapy and other conditions. Some of the major products in clinical diagnostics market include instruments, reagents and software. Instruments segment includes many devices such as chromatography instruments, molecular diagnostics instruments, immunoassay instruments, hematology instruments and others. Reagents are consumable components or chemicals used to perform various diagnostic tests. Software segment includes clinical diagnostic data management software used for collecting, managing and analyzing clinical laboratory data.

The global clinical diagnostic market is estimated to be valued at US$ 96.01 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics
The increase in prevalence of chronic diseases and growing geriatric population are expected to drive the growth of clinical diagnostic market over the forecast period. It is estimated that by 2030 around 67% of all deaths will be caused due to chronic diseases according to the World Health Organization. Chronic diseases require long term diagnostic monitoring which contributes to the demand of clinical diagnostic products. Moreover, growing geriatric population also tends to suffer more from chronic illnesses driving the need for clinical diagnostics. According to United Nations, number of people aged 60 years and above is expected to rise from 962 million globally in 2017 to 2.1 billion by 2050.

Segment Analysis
The global clinical diagnostic market is segmented into product and services, application, and end user. By product and services, the reagents and kits sub segment dominates the market, accounting for around 40% market share in 2024. The dominance is attributed to high consumption of reagents and kits in diagnostic procedures.

PEST Analysis
Political: Globalization and free trade between countries has increased movement of goods and services across borders, providing growth opportunities to clinical diagnostic market players. However, stringent regulations pertaining to new product approval may hinder market growth to some extent.
Economic: Rising healthcare expenditure along with increasing incidence of chronic and infectious diseases worldwide are driving the clinical diagnostic market. Growing geriatric population, which is more prone to various diseases, is another major factor fueling market growth.
Social: Increased awareness about early detection and prevention of diseases has boosted demand for clinical diagnostic testing. Moreover, rapid urbanization and changing lifestyle leading to unhealthy food habits and lack of physical activity are key social factors propelling market expansion.
Technological: Adoption of automation, artificial intelligence, big data analytics, and molecular diagnostics in clinical testing is assisting in improved disease diagnosis and management. Development of miniaturized point-of-care testing devices is also expected to positively impact the market during the forecast period.

Key Takeaways

The Global Clinical Diagnostic Market Demand is expected to witness high growth. The global clinical diagnostic market is estimated to be valued at US$ 96.01 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.

Regional analysis comprises - North America dominates the global market currently owing to advanced healthcare infrastructure and widespread health insurance coverage in the region, especially in the US. Asia Pacific clinical diagnostic market is poised to grow at fastest pace during the forecast period supported by rising healthcare spending, increasing penetration of leading market players, and improving healthcare infrastructure across developing countries in the region.

Key players operating in the clinical diagnostic market are NVIDIA Corporation, Advanced Micro Devices Inc., Amazon Web Series, NEC Corporation, Lenovo Group Ltd., Hewlett Packard Enterprise, Dassault Systemes SE, Sugon Information Industry Co. Ltd., Dell Technologies Inc., Fujistu Ltd., Microsoft Corporation, Intel Corporation, and International Business Machines Corporation. Key players are focusing on new product launches, agreements, partnerships and acquisitions to gain competitive edge in the market.

For more insights, Read- https://www.ukwebwire.com/clinical-diagnostic-market-growth-demand-and-overview/

Get more insights on this topic: https://www.insightprobing.com/neurological-biomarkers-market-size-and-share-2/